Harnessing Immunity to Halt Cancer

One of cancer’s biggest weapons is its ability to hide from the immune system, the very system that is designed to destroy it. This immune evasion is a major reason cancer treatments fail.

We have identified a pathway to block immune evasion and developed a first-in-class small-molecule inhibitor. Our drug is orally administered, safe for patients, and does not rely on a protein target, which makes it eligible for a larger patient population.